{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:10:58Z","timestamp":1793722258590,"version":"4.6.1"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2024-156862OB-I00"],"award-info":[{"award-number":["PID2024-156862OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["CPP2023-010425"],"award-info":[{"award-number":["CPP2023-010425"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["CPP2024-011282"],"award-info":[{"award-number":["CPP2024-011282"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Allergic inflammation arises from a dysregulated immune response in which immunoglobulin E (IgE) plays a central pathogenic role. By binding to its high-affinity Fc\u03b5RI on mast cells and basophils, IgE orchestrates the rapid activation and mediator release that underlies immediate hypersensitivity reactions. Compelling experimental evidence indicates that the pathogenic role of IgE extends well beyond of the mere effector cells degranulation, contributing also to shape antigen presentation, to regulate the function of dendritic cells, and to endorse an immune environment that favours type 2 inflammation. Within this complex network, regulatory T cells (Tregs) serve as a critical counterbalance, maintaining tolerance to environmental allergens and restraining excessive type 2 inflammatory responses. Individuals with allergic diseases often display quantitative and\/or functional alterations within the Tregs compartment, including signs of phenotypic plasticity shifted toward pro-allergic states. These observations raise important questions about how IgE-mediated signalling pathways might directly or indirectly impair proper Tregs development or stability. In this context, anti-IgE therapies such as omalizumab have shown that, beyond reducing free IgE levels and downregulating Fc\u03b5RI expression, they may also promote the expansion or restoration of Tregs, which might well contribute to the reestablishment of immune tolerance. Deciphering the interplay among IgE, Tregs, and anti-IgE agents can help to pave the way towards the development of innovative disease-modifying strategies for allergic diseases and other inflammatory immune-mediated diseases.<\/jats:p>","DOI":"10.3389\/falgy.2026.1759921","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:46:58Z","timestamp":1770187618000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["IgE, anti-IgE therapy, and regulatory T cells: new paradigms in allergic inflammation"],"prefix":"10.3389","volume":"7","author":[{"given":"C.","family":"Benito-Villalvilla","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University","place":["Madrid, Spain"]},{"name":"Department of Biochemistry and Molecular Biology, School of Medicine, Complutense University","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Angelina","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mart\u00edn-Cruz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University","place":["Madrid, Spain"]},{"name":"Department of Biochemistry and Molecular Biology, School of Pharmacy, Complutense University","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sirvent","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Palomares","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41573-023-00750-1","article-title":"Type 2 chronic inflammatory diseases: targets, therapies and unmet needs","volume":"22","author":"Kolkhir","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"B2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41577-021-00538-7","article-title":"Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?","volume":"21","author":"Akdis","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41423-025-01261-2","article-title":"Type 2 immunity in allergic diseases","volume":"22","author":"Ogulur","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/all.14318","article-title":"Type 2 immunity in the skin and lungs","volume":"75","author":"Akdis","year":"2020","journal-title":"Allergy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1681147","DOI":"10.3389\/falgy.2025.1681147","article-title":"Epithelial-derived cytokines in the pathogenesis of severe asthma","volume":"6","author":"Pham","year":"2025","journal-title":"Front Allergy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/all.16459","article-title":"The direct and indirect role of IgE on airway epithelium in asthma","volume":"80","author":"Domingo","year":"2025","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e70057","DOI":"10.1111\/imr.70057","article-title":"IgE in allergic diseases","volume":"334","author":"Greene","year":"2025","journal-title":"Immunol Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41467-019-13815-w","article-title":"The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab","volume":"11","author":"Gasser","year":"2020","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jaci.2009.10.021","article-title":"Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1084\/jem.20101563","article-title":"Inflammatory dendritic cells\u2013not basophils\u2013are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen","volume":"207","author":"Hammad","year":"2010","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1111\/all.14724","article-title":"The role of CD23 in the regulation of allergic responses","volume":"76","author":"Engeroff","year":"2021","journal-title":"Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e70031","DOI":"10.1111\/imr.70031","article-title":"Structural and functional insights into IgE receptor interactions and disruptive inhibition","volume":"331","author":"Eggel","year":"2025","journal-title":"Immunol Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/all.14308","article-title":"Past, present, and future of anti-IgE biologics","volume":"75","author":"Guntern","year":"2020","journal-title":"Allergy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/imr.13380","article-title":"Therapeutic monoclonal antibodies in allergy: targeting IgE, cytokine, and alarmin pathways","volume":"328","author":"Eggel","year":"2024","journal-title":"Immunol Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1111\/all.15449","article-title":"Regulatory T cells and immunoglobulin E: a new therapeutic link for autoimmunity?","volume":"77","author":"Palomares","year":"2022","journal-title":"Allergy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1159\/000536335","article-title":"The role of regulatory T cells in allergic diseases: collegium internationale allergologicum (CIA) update 2024","volume":"185","author":"Martin-Cruz","year":"2024","journal-title":"Int Arch Allergy Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/all.16326","article-title":"Regulatory T cells and their role in allergic disease","volume":"80","author":"Conrad","year":"2025","journal-title":"Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.jaci.2005.08.046","article-title":"Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice","volume":"116","author":"Lin","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.celrep.2018.01.048","article-title":"B1 cell IgE impedes mast cell-mediated enhancement of parasite expulsion through B2 IgE blockade","volume":"22","author":"Martin","year":"2018","journal-title":"Cell Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today","volume":"8","author":"Gould","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaci.2015.08.005","article-title":"IgE antibodies, FcepsilonRIalpha, and IgE-mediated local anaphylaxis can limit snake venom toxicity","volume":"137","author":"Starkl","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e70024","DOI":"10.1111\/imr.70024","article-title":"IgE-mediated activation of mast cells and basophils in health and disease","volume":"331","author":"Charles","year":"2025","journal-title":"Immunol Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.4049\/jimmunol.170.2.775","article-title":"Long term maintenance of IgE-mediated memory in mast cells in the absence of detectable serum IgE","volume":"170","author":"Kubo","year":"2003","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nsmb.2044","article-title":"Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcvarepsilonRI","volume":"18","author":"Holdom","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-immunol-061020-053712","article-title":"IgE, IgE receptors and Anti-IgE biologics: protein structures and mechanisms of action","volume":"41","author":"McDonnell","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nri2072","article-title":"New developments in FcepsilonRI regulation, function and inhibition","volume":"7","author":"Kraft","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000527481","article-title":"Allergy, anaphylaxis, and nonallergic hypersensitivity: IgE, mast cells, and beyond","volume":"31","author":"Vitte","year":"2022","journal-title":"Med Princ Pract"},{"key":"B29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nri914","article-title":"Regulation of mast-cell and basophil function and survival by IgE","volume":"2","author":"Kawakami","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"40261","DOI":"10.1074\/jbc.M506063200","article-title":"Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit","volume":"280","author":"Iwaki","year":"2005","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"668131","DOI":"10.3389\/fcell.2021.668131","article-title":"Targeting Bruton\u2019s tyrosine kinase in inflammatory and autoimmune pathologies","volume":"9","author":"Neys","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4049\/jimmunol.1003392","article-title":"High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation","volume":"187","author":"Sallmann","year":"2011","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s00018-015-1870-x","article-title":"The role of FcepsilonRI expressed in dendritic cells and monocytes","volume":"72","author":"Shin","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.4049\/jimmunol.175.9.5724","article-title":"TLR9- And FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression","volume":"175","author":"Schroeder","year":"2005","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.jaci.2017.07.035","article-title":"Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab","volume":"141","author":"Gill","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"107978","DOI":"10.1016\/j.intimp.2021.107978","article-title":"Programmed death ligand 1 (PD-L1) plays a vital part in DC tolerogenicity induced by IFN-gamma","volume":"99","author":"Svajger","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2016.07.004","article-title":"IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity","volume":"75","author":"Lippens","year":"2016","journal-title":"J Autoimmun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic control of the foxp3 locus in regulatory T cells","volume":"5","author":"Floess","year":"2007","journal-title":"PLoS Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10772","article-title":"Extrathymically generated regulatory T cells control mucosal TH2 inflammation","volume":"482","author":"Josefowicz","year":"2012","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.4049\/jimmunol.0901194","article-title":"Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells","volume":"184","author":"Gill","year":"2010","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3389\/fimmu.2018.00689","article-title":"Immunoglobulin E-mediated autoimmunity","volume":"9","author":"Maurer","year":"2018","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41590-023-01469-2","article-title":"How autoreactive thymocytes differentiate into regulatory versus effector CD4(+) T cells after avoiding clonal deletion","volume":"24","author":"Tai","year":"2023","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","article-title":"Regulatory T cell development","volume":"38","author":"Savage","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/all.15993","article-title":"Deciphering the factors determining the differentiation of autoreactive thymocytes into regulatory T cells","volume":"79","author":"Benito-Villalvilla","year":"2024","journal-title":"Allergy"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1154575","DOI":"10.3389\/fimmu.2023.1154575","article-title":"Regulatory T cells in peripheral tissue tolerance and diseases","volume":"14","author":"Cheru","year":"2023","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/j.cell.2025.03.020","article-title":"Rorgammat-positive dendritic cells are required for the induction of peripheral regulatory T cells in response to oral antigens","volume":"188","author":"Rodrigues","year":"2025","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/s41423-023-01096-9","article-title":"A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells","volume":"20","author":"Martin-Cruz","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/cea.14092","article-title":"Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells","volume":"52","author":"Angelina","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"B52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41385-021-00455-x","article-title":"Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming","volume":"15","author":"Angelina","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1038\/s41467-025-62632-x","article-title":"A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease","volume":"16","author":"Sevilla-Ortega","year":"2025","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/imr.12555","article-title":"Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells","volume":"278","author":"Palomares","year":"2017","journal-title":"Immunol Rev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5414\/ALX02300E","article-title":"Mechanisms in AIT: insights 2021","volume":"6","author":"Satitsuksanoa","year":"2022","journal-title":"Allergol Select"},{"key":"B56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41573-024-01089-x","article-title":"Harnessing the biology of regulatory T cells to treat disease","volume":"24","author":"Wardell","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"B57","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41590-018-0280-2","article-title":"Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells","volume":"20","author":"Akkaya","year":"2019","journal-title":"Nat Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"8437","DOI":"10.2147\/OTT.S221340","article-title":"The role of PD-1\/PD-L1 axis in treg development and function: implications for cancer immunotherapy","volume":"12","author":"Cai","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.celrep.2017.10.090","article-title":"Reciprocal expression of IL-35 and IL-10 defines two distinct effector treg subsets that are required for maintenance of immune tolerance","volume":"21","author":"Wei","year":"2017","journal-title":"Cell Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","article-title":"Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance","volume":"27","author":"Cao","year":"2007","journal-title":"Immunity"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"111248","DOI":"10.1016\/j.isci.2024.111248","article-title":"Interleukin-2 receptor signaling acts as a checkpoint that influences the distribution of regulatory T cell subsets","volume":"27","author":"Shouse","year":"2024","journal-title":"iScience"},{"key":"B64","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5114\/ada.2021.106202","article-title":"Relationship between CCR5(+)FoxP3(+) Treg cells and forced expiratory volume in 1 s, peak expiratory flow in patients with severe asthma","volume":"38","author":"Kraszula","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/all.15145","article-title":"Increased circulating CRTH2(+) Tregs are associated with asthma control and exacerbation","volume":"77","author":"Chantveerawong","year":"2022","journal-title":"Allergy"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/all.16439","article-title":"Deciphering dysfunctional regulatory T cells in atopic dermatitis","volume":"80","author":"Kang","year":"2025","journal-title":"Allergy"},{"key":"B67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jaci.2007.11.003","article-title":"Analysis of CD25hiCD4+ \u201cregulatory\u201d T-cell subtypes in atopic dermatitis reveals a novel T(H)2-like population","volume":"121","author":"Reefer","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.immuni.2015.02.004","article-title":"Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy","volume":"42","author":"Rivas","year":"2015","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.immuni.2020.10.002","article-title":"Regulatory T cell-derived TGF-beta1 controls multiple checkpoints governing allergy and autoimmunity","volume":"53","author":"Turner","year":"2020","journal-title":"Immunity"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jaci.2007.02.023","article-title":"Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma","volume":"119","author":"Hartl","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jaci.2008.11.037","article-title":"Selective deregulation in chemokine signaling pathways of CD4+ CD25(hi)CD127(lo)\/(-) regulatory T cells in human allergic asthma","volume":"123","author":"Nguyen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00405-019-05304-z","article-title":"Decreased Treg-derived miR-181a and miR-155 correlated with reduced number and function of Treg cells in allergic rhinitis children","volume":"276","author":"Liu","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/all.13822","article-title":"Naive regulatory T cells in infancy: associations with perinatal factors and development of food allergy","volume":"74","author":"Collier","year":"2019","journal-title":"Allergy"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s41591-019-0461-z","article-title":"Microbiota therapy acts via a regulatory T cell MyD88\/RORgammat pathway to suppress food allergy","volume":"25","author":"Abdel-Gadir","year":"2019","journal-title":"Nat Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9230","DOI":"10.1038\/s41467-024-53384-1","article-title":"The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials","volume":"15","author":"Silverberg","year":"2024","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.2426","article-title":"Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions","volume":"17","author":"Chung","year":"2011","journal-title":"Nat Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41232-021-00164-9","article-title":"Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases","volume":"41","author":"Hao","year":"2021","journal-title":"Inflamm Regen"},{"key":"B78","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/all.14639","article-title":"Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy","volume":"76","author":"Yao","year":"2021","journal-title":"Allergy"},{"key":"B79","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaci.2019.02.008","article-title":"Allergen immunotherapy improves defective follicular regulatory T cells in patients with allergic rhinitis","volume":"144","author":"Yao","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e171241","DOI":"10.1172\/jci.insight.171241","article-title":"T follicular regulatory cells in food allergy promote IgE via IL-4","volume":"9","author":"Chen","year":"2024","journal-title":"JCI Insight"},{"key":"B81","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.alit.2024.08.004","article-title":"Regulation of the IgE response by T follicular regulatory cells","volume":"74","author":"Dent","year":"2025","journal-title":"Allergol Int"},{"key":"B82","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0952-7915(97)80182-3","article-title":"Therapeutic potential of anti-IgE antibodies","volume":"9","author":"Heusser","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/72601","article-title":"The pharmacological basis of anti-IgE therapy","volume":"18","author":"Chang","year":"2000","journal-title":"Nat Biotechnol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e70002","DOI":"10.1002\/clt2.70002","article-title":"GA(2)LEN ANACARE consensus statement: potential of omalizumab in food allergy management","volume":"14","author":"Zuberbier","year":"2024","journal-title":"Clin Transl Allergy"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1255","DOI":"10.1002\/cti2.1255","article-title":"Ligelizumab treatment for severe asthma: learnings from the clinical development programme","volume":"10","author":"Trischler","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaci.2024.10.033","article-title":"Low-dose IL-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial","volume":"155","author":"Rosenzwajg","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2000751","DOI":"10.1183\/13993003.00751-2020","article-title":"Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3(+)Tregs","volume":"57","author":"Lopez-Abente","year":"2021","journal-title":"Eur Respir J"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/s41590-019-0472-4","article-title":"Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses","volume":"20","author":"Clement","year":"2019","journal-title":"Nat Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/cea.12839","article-title":"Control of asthma by omalizumab: the role of CD4(+) Foxp3(+) regulatory T cells","volume":"46","author":"Amat","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B90","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/thx.2006.067793","article-title":"Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge","volume":"62","author":"Bratke","year":"2007","journal-title":"Thorax"},{"key":"B91","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jaci.2010.04.006","article-title":"Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma","volume":"126","author":"Dua","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jaci.2009.07.009","article-title":"Plasmacytoid dendritic cells during infancy are inversely associated with childhood respiratory tract infections and wheezing","volume":"124","author":"Upham","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/all.15567","article-title":"Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-alpha production and FOXP3(+) Treg generation","volume":"78","author":"Benito-Villalvilla","year":"2023","journal-title":"Allergy"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1111\/all.16517","article-title":"The role of IgE in Crohn\u2019s disease by impairing the capacity of plasmacytoid dendritic cells to generate FOXP3(+) Tregs","volume":"80","author":"de la Rocha-Munoz","year":"2025","journal-title":"Allergy"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1093\/ibd\/izaf072","article-title":"A guide to the patient-centric use of vedolizumab for Crohn\u2019s disease","volume":"31","author":"Rubin","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41424-018-0054-z","article-title":"Co-occurrence of asthma and the inflammatory bowel diseases: a systematic review and meta-analysis","volume":"9","author":"Kuenzig","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.hrtlng.2023.10.004","article-title":"Causal relationship between asthma and inflammatory bowel disease: a two-sample bidirectional mendelian randomization analysis","volume":"63","author":"Lai","year":"2024","journal-title":"Heart Lung"},{"key":"B98","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/ph18030437","article-title":"Omalizumab and oral immunotherapy in IgE-mediated food allergy in children: a systematic review and a meta-analysis","volume":"18","author":"Buono","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/j.jaip.2021.01.011","article-title":"Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies","volume":"9","author":"Bousquet","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e70062","DOI":"10.1002\/clt2.70062","article-title":"T cell immunophenotypes and IgE responses in patients with moderate-to-severe atopic dermatitis receiving dupilumab","volume":"15","author":"Redhu","year":"2025","journal-title":"Clin Transl Allergy"},{"key":"B101","doi-asserted-by":"publisher","first-page":"115385","DOI":"10.1016\/j.biopha.2023.115385","article-title":"The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma","volume":"166","author":"Bergantini","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/sji.13031","article-title":"Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab","volume":"94","author":"Bergantini","year":"2021","journal-title":"Scand J Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/all.16423","article-title":"Allergen-specific immunotherapy and trained immunity","volume":"80","author":"Martin-Cruz","year":"2025","journal-title":"Allergy"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jaci.2024.09.009","article-title":"Trained immunity-based vaccines for infections and allergic diseases","volume":"154","author":"Martin-Cruz","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"114624","DOI":"10.1016\/j.intimp.2025.114624","article-title":"Exploiting regulatory T cells (tregs): cutting-edge therapy for autoimmune diseases","volume":"155","author":"Hassan","year":"2025","journal-title":"Int Immunopharmacol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1759921\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:46:59Z","timestamp":1770187619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1759921\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":105,"alternative-id":["10.3389\/falgy.2026.1759921"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2026.1759921","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"article-number":"1759921"}}